by ADRIAN MANZ | Nov 5, 2025 | The Doctor's Dose
Bank of America Stock Slides Despite Higher Profit Targets at First Investor Day Since 2011 Bank of America (BAC) shares fell on Wednesday even as the bank’s leadership raised profitability and growth targets during its first investor day in 14 years. The event, held...
by ADRIAN MANZ | Nov 4, 2025 | The Doctor's Dose
S&P 500 and Nasdaq Post Biggest Drop in Nearly a Month The S&P 500 and Nasdaq Composite recorded their sharpest one-day declines in nearly a month on Wednesday, as Wall Street investors rotated out of high-flying technology and AI stocks amid growing caution...
by ADRIAN MANZ | Oct 30, 2025 | The Doctor's Dose
Core Scientific Shareholders Reject $9 Billion Merger with CoreWeave Core Scientific shareholders have voted down a $9 billion all-stock merger with CoreWeave, abruptly ending one of the most closely watched transactions in the AI data center sector. The vote, which...
by ADRIAN MANZ | Oct 30, 2025 | The Doctor's Dose
Google, Meta, and Microsoft Spend $80 Billion on AI as Investor Reactions Diverge Google, Meta, and Microsoft collectively spent almost $80 billion last quarter on artificial intelligence infrastructure — a record-breaking wave of investment that drew starkly...
by ADRIAN MANZ | Oct 30, 2025 | The Doctor's Dose
Meta Plans $25 Billion Bond Sale to Fund Soaring AI Infrastructure Costs Meta Platforms is preparing to raise as much as $25 billion in one of the largest corporate bond sales of the year, as the company accelerates spending to expand its artificial intelligence...
by ADRIAN MANZ | Oct 29, 2025 | The Doctor's Dose
Future Fed Rate Cuts ‘Far’ From Certain After a Divided Meeting The Federal Reserve delivered a second straight 25 bp rate cut, trimming the federal-funds target range to 3.75%–4.00%. But Chair Jerome Powell used the press conference to puncture confidence in another...
by ADRIAN MANZ | Oct 29, 2025 | The Doctor's Dose
Meta Shares Drop as AI Spending Surges Despite Record Revenue Meta Platforms posted record third-quarter revenue but warned of a major spike in spending on artificial-intelligence infrastructure, sending its stock tumbling more than 8% in after-hours trading. The...
by ADRIAN MANZ | Oct 29, 2025 | The Doctor's Dose
Palantir Stock Climbs Ahead of Earnings as Investors Speculate on Stock Split Palantir Technologies shares continue to surge into the company’s third-quarter earnings, with retail investors fixated on the possibility of the firm’s first-ever stock split. The...
by ADRIAN MANZ | Oct 28, 2025 | The Doctor's Dose
Apple Services Revenue Tops $100 Billion Amid App Store Scrutiny Apple is on track to surpass $100 billion in annual revenue from its services business for the first time, marking a major milestone for the tech giant even as it faces mounting legal and regulatory...
by ADRIAN MANZ | Oct 28, 2025 | The Doctor's Dose
OpenAI Completes For-Profit Conversion, Paving Way for IPO and Pushing Microsoft Past $4 Trillion. The AI leader’s shift to a public-benefit corporation unlocks new funding avenues, cements Microsoft’s 27% stake, and sets the stage for one of the most anticipated IPOs...
